https://imagionbiosystems.com/news/imagion-presents-magsense-inte...

https://imagionbiosystems.com/news/imagion-presents-magsense-interim-study-results-at-breast-cancer-meeting/

You are correct in your above summary post. And, if we peel back the "San Antonio Breast Cancer
Symposium" information that was posted today (See Above Link) we find that once again the Co
is validating the credibility of the technology. In my eyes at least, with all that we know from the
first cohort results and the results that have been received from the second cohort, the Co has
received the outcome that we were all expecting from this trial.


One caveat in my mind is whether we will receive completed results on the second cohort before
the year's end, and hence how realistic is it that we do? Regardless, I'm confident that things are
moving in the right direction (albeit at a much slower pace than anticipated)...certainly plausible
that we receive something on cohort II, but, we will know soon enough. Each update on results
from patients is helping to color in the big picture here.